Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.
Magnus Bäck, Arif Yurdagul, Ira Tabas...
https://pubmed.ncbi.nlm.nih.gov/30846875/Actively Recruiting
Led by Mario Negri Institute for Pharmacological Research · Updated on 2026-10-09
324
Participants Needed
9
Research Sites
13 weeks
Total Duration
Researchers are studying how diets supplemented with polyunsaturated fatty acids PUFAs from animal or plant sources affect chronic inflammation linked to cardiovascular risk. The study focuses on people over 55 with moderate to high cardiovascular risk but without established cardiovascular disease. It aims to better understand how these dietary changes influence a lipid and inflammation-related risk score and improve overall cardiovascular prevention by addressing chronic inflammation. Participants are randomly assigned to one of three diets fish oil supplementation providing omega-3 fatty acids DHA and EPA, camelina oil supplementation rich in alpha-linolenic acid ALA plus vitamin E, or a regular non-enriched diet with vitamin E. The study product is taken daily for 12 weeks, with doses standardized to ensure comparable vitamin E intake. The supplementation is administered before meals, and all products are provided by the study team. During the study, participants undergo a baseline clinical visit with blood sampling, heart rate, blood pressure, and waist circumference measurements, and complete a dietary questionnaire. After 12 weeks, these assessments are repeated along with monitoring diet tolerance and any clinical events. Blood samples are stored and analyzed centrally to evaluate changes in lipid and inflammatory biomarkers. The study plans to enroll 324 participants, with outcomes measured primarily by changes in a lipidomicinflammation-based risk score over 12 weeks.
CONDITIONS
RESOLving INflammation Through Diet for Health (RESOLVIN)
J
Jennifer Meessen, phD
A
Antonella Vasamì, High school diploma
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mario Negri Institute for Pharmacological Research
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants take daily supplementation of fish oil, camelina oil with vitamin E, or a regular diet with vitamin E for 12 weeks.
Baseline and 12-week follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Magnus Bäck, Arif Yurdagul, Ira Tabas...
https://pubmed.ncbi.nlm.nih.gov/30846875/Frank L J Visseren, François Mach, Yvo M Smulders...
https://pubmed.ncbi.nlm.nih.gov/34458905/Paul M Ridker, Brendan M Everett, Tom Thuren...
https://pubmed.ncbi.nlm.nih.gov/28845751/José Tuñón, Lina Badimón, Marie-Luce Bochaton-Piallat...
https://pubmed.ncbi.nlm.nih.gov/30534957/Mario Negri Institute for Pharmacological Research
Lead Sponsor